Genetically encoded FRET-based biosensor for imaging MMP-9 activity

Biomaterials

Volumn 35, Issue 5, 2014, Pages 1402-1410

  Stawarski, Michal ^a   Rutkowska Wlodarczyk, Izabela ^a   Zeug, André ^b   Bijata, Monika ^a   Madej, Hubert ^a,c   Kaczmarek, Leszek ^a   Wlodarczyk, Jakub ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Biosensors; Cancer related processes; F rster resonance energy transfer (FRET); Long term memory; Matrix metalloproteinase 9; Quantitative microscopy

Indexed keywords

BIOLOGICAL FUNCTIONS; LEARNING AND MEMORY; LONG TERM MEMORY; MATRIX METALLOPROTEINASE-9; PROTEOLYTIC ACTIVITIES; QUANTITATIVE MICROSCOPY; RESONANCE ENERGY TRANSFER; SUBCELLULAR RESOLUTION;

CELL MEMBRANES; DISEASES; ENERGY TRANSFER;

BIOSENSORS;

GELATINASE B; MUTANT PROTEIN; PROTEINASE;

ANIMAL CELL; ARTICLE; BIOLOGICAL FUNCTIONS; BIOSENSOR; BLEACHING; BRAIN CELL CULTURE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME LOCALIZATION; ENZYME RELEASE; FLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC CODE; HIPPOCAMPAL NEURONAL CULTURE; IN VITRO STUDY; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT; TUMOR CELL CULTURE;

BIOSENSORS; CANCER-RELATED PROCESSES; FÖRSTER RESONANCE ENERGY TRANSFER (FRET); LONG-TERM MEMORY; MATRIX METALLOPROTEINASE 9; QUANTITATIVE MICROSCOPY;

BASE SEQUENCE; BIOSENSING TECHNIQUES; CELL MEMBRANE; DNA PRIMERS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HUMANS; KINETICS; MATRIX METALLOPROTEINASE 9; PROTEOLYSIS;

EID: 84890191222     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.11.033     Document Type: Article

References (50)

1. 2+ in multiple cellular locations. PLoS One 2012, 7:e49371.
2. Burdette S.C., Walkup G.K., Spingler B., Tsien R.Y., Lippard S.J. Fluorescent sensors for Zn2+ based on a fluorescein platform:synthesis, properties and intracellular distribution. JAm Chem Soc 2001, 123:7831-7841.
3. Esposito A., Gralle M., Dani M.A.C., Lange D., Wouters F.S. pHlameleons: a family of FRET-based protein sensors for quantitative pH imaging. Biochemistry 2008, 47:13115-13126.
4. Gruenwald K., Holland J.T., Stromberg V., Ahmad A., Watcharakichkorn D., Okumoto S. Visualization of glutamine transporter activities in living cells using genetically encoded glutamine sensors. PLoS One 2012, 7:e38591.
5. Kaláb P., Soderholm J. The design of Förster (fluorescence) resonance energy transfer (FRET)-based molecular sensors for Ran GTPase. Methods 2010, 51:220-232.
6. Violin J.D., Zhang J., Tsien R.Y., Newton A.C. Agenetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. JCell Biol 2003, 161:899-909.
7. Meng F., Sachs F. Visualizing dynamic cytoplasmic forces with a compliance-matched FRET sensor. JCell Sci 2011, 124:261-269.
8. Klein T., Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 2011, 41:271-290.
9. Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006, 25:9-34.
10. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
11. Hanemaaijer R., Verheijen J.H., Maguire T.M., Visser H., Toet K., McDermott E., et al. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int J Cancer 2000, 86:204-207.
12. Schmalfeldt B., Prechtel D., Härting K., Späthe K., Rutke S., Konik E., et al. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 2001, 7:2396-2404.
13. Schönbeck U., Mach F., Libby P. Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. JImmunol 1998, 161:3340-3346.
14. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 2000, 14:163-176.
15. Klein G., Vellenga E., Fraaije M.W., Kamps W.A., de Bont E.S. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol 2004, 50:87-100.
16. Bozdagi O., Nagy V., Kwei K.T., Huntley G.W. Invivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. JNeurophysiol 2007, 98:334-344.
17. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., et al. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. JNeurosci 2006, 26:1923-1934.
18. Okulski P., Jay T.M., Jaworski J., Duniec K., Dzwonek J., Konopacki F.A., et al. TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biol Psychiatry 2007, 62:359-362.
19. Huntley G.W. Synaptic circuit remodelling by matrix metalloproteinases in health and disease. Nat Rev Neurosci 2012, 13:743-757.
20. Bilousova T.V., Dansie L., Ngo M., Aye J., Charles J.R., Ethell D.W., et al. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. JMed Genet 2009, 46:94-102.
21. Michaluk P., Wawrzyniak M., Alot P., Szczot M., Wyrembek P., Mercik K., et al. Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology. JCell Sci 2011, 124:3369-3380.
22. Wang X.B., Bozdagi O., Nikitczuk J.S., Zhai Z.W., Zhou Q., Huntley G.W. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proc Natl Acad Sci U S A 2008, 105:19520-19525.
23. Wlodarczyk J., Mukhina I., Kaczmarek L., Dityatev A. Extracellular matrix molecules, their receptors, and secreted proteases in synaptic plasticity. Dev Neurobiol 2011, 71:1040-1053.
24. Szklarczyk A., Lapinska J., Rylski M., McKay R.D.G., Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. JNeurosci 2002, 22:920-930.
25. Wilczynski G.M., Konopacki F.A., Wilczek E., Lasiecka Z., Gorlewicz A., Michaluk P., et al. Important role of matrix metalloproteinase 9 in epileptogenesis. JCell Biol 2008, 180:1021-1035.
26. Szepesi Z., Bijata M., Ruszczycki B., Kaczmarek L., Wlodarczyk J. Matrix metalloproteinases regulate the formation of dendritic spine head protrusions during chemically induced long-term potentiation. PLoS One 2013, 8:e63314.
27. Fudala R., Ranjan A.P., Mukerjee A., Vishwanatha J.K., Gryczynski Z., Borejdo J., et al. Fluorescence detection of MMP-9. I. MMP-9 selectively cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys peptide. Curr Pharm Biotechnol 2011, 12:834-838.
28. Akers W.J., Xu B., Lee H., Sudlow G.P., Fields G.B., Achilefu S., et al. Detection of MMP-2 and MMP-9 activity invivo with a triple-helical peptide optical probe. Bioconjug Chem 2012, 23:656-663.
29. Roopali Roy D.Z., Pories Susan, Moss Marcia L., Moses Marsha A. Potential of fluorescent metalloproteinase substrates for cancer detection. Clin Biochem 2011, 44:1434-1439.
30. Hawkins K.E., Demars K.M., Yang C., Rosenberg G.A., Candelario-Jalil E. Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke. Mol Brain 2013, 6:14.
31. Leight J.L., Alge D.L., Maier A.J., Anseth K.S. Direct measurement of matrix metalloproteinase activity in 3D cellular microenvironments using a fluorogenic peptide substrate. Biomaterials 2013, 34:7344-7352.
32. Wang W., Shao R., Wu Q., Ke S., McMurray J., Lang F., et al. Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide. Mol Imaging Biol 2009, 11:424-433.
33. Scherer R., McIntyre J.O., Matrisian L. Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev 2008, 27:679-690.
34. Lee C.-M., Jang D., Cheong S.-J., Jeong M.-H., Kim E.-M., Kim D.W., et al. Optical imaging of MMP expression and cancer progression in an inflammation-induced colon cancer model. Int J Cancer 2012, 131:1846-1853.
35. Kaijzel E.L., van Heijningen P.M., Wielopolski P.A., Vermeij M., Koning G.A., van Cappellen W.A., et al. Multimodality imaging reveals a gradual increase in matrix metalloproteinase activity at aneurysmal lesions in live fibulin-4 mice. Circ Cardiovasc Imaging 2010, 3:567-577.
36. Wallis de Vries B.M., Hillebrands J.-L., van Dam G.M., Tio R.A., de Jong J.S., Slart R.H.J.A., et al. Multispectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a matrix-degrading metalloproteinase-sensitive activatable fluorescent probe. Circulation 2009, 119:e534-e536.
37. Kridel S.J., Chen E., Kotra L.P., Howard E.W., Mobashery S., Smith J.W. Substrate hydrolysis by matrix metalloproteinase-9. JBiol Chem 2001, 276:20572-20578.
38. Fudala R., Mukerjee A., Ranjan A.P., Vishwanatha J.K., Kurdowska A.K., Gryczynski Z., et al. Fluorescence detection of MMP-9.II. Ratiometric FRET-based sensing with dually labeled specific peptide. Curr Pharm Biotechnol 2012.
39. Nagai T., Ibata K., Park E.S., Kubota M., Mikoshiba K., Miyawaki A. Avariant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 2002, 20:87-90.
40. Li M.Z., Elledge S.J. Harnessing homologous recombination invitro to generate recombinant DNA via SLIC. Nat Methods 2007, 4:251-256.
41. Michaluk P., Kolodziej L., Mioduszewska B., Wilczynski G.M., Dzwonek J., Jaworski J., et al. β-Dystroglycan as a target for MMP-9, in response to enhanced neuronal activity. JBiol Chem 2007, 282:16036-16041.
42. Michaluk P., Mikasova L., Groc L., Frischknecht R., Choquet D., Kaczmarek L. Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin β1 signaling. JNeurosci 2009, 29:6007-6012.
43. Otmakhov N., Khibnik L., Otmakhova N., Carpenter S., Riahi S., Asrican B., et al. Forskolin-induced LTP in the CA1 hippocampal region is NMDA receptor dependent. JNeurophysiol 2004, 91:1955-1962.
44. Zeug A., Woehler A., Neher E., Ponimaskin Evgeni G. Quantitative intensity-based FRET approaches a comparative snapshot. Biophys J 2012, 103:1821-1827.
45. Day R.N., Booker C.F., Periasamy A. Characterization of an improved donor fluorescent protein for Förster resonance energy transfer microscopy. JBiomed Opt 2008, 13:031203.
46. Evers T.H., van Dongen E.M.W.M., Faesen A.C., Meijer E.W., Merkx M. Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers. Biochemistry 2006, 45:13183-13192.
47. Chen N., Zou J., Wang S., Ye Y., Huang Y., Gadda G., et al. Designing protease sensors for real-time imaging of trypsin activation in pancreatic cancer cells. Biochemistry 2009, 48:3519-3526.
48. Woehler A., Wlodarczyk J., Neher E. Signal/noise analysis of FRET-based sensors. Biophys J 2010, 99:2344-2354.
49. Niedringhaus M., Chen X., Dzakpasu R., Conant K. MMPs and soluble ICAM-5 increase neuronal excitability within invitro networks of hippocampal neurons. PLoS One 2012, 7:e42631.
50. Tsien R.Y. Very long-term memories may be stored in the pattern of holes in the perineuronal net. Proc Natl Acad Sci U S A 2013, 110:12456-12461.